Form D · Biotechnology
Equinext, LLC
Lexington, KY · CIK 0001536165
Offering snapshot reported Dec 4, 2013 · SEC filing
- Reported sold
- $300K Offering amount: $500K
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Feb 15, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 4, 2013 | Initial | $300,000 | No comparison | 11 | SEC filing |
| Dec 1, 2011 | Initial | $685,003 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-207367
Source: Form D, filed Dec 4, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Clark | Director |
| Eric Hauck | Executive |
| Thomas Hedman | Director |
| Jim Newberry | Director |
| Kim Sprayberry | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1501 Bull Lea Road Suite 103
Lexington, KY, 40511
Lexington, KY, 40511